METROPOLITAN LIFE INSURANCE CO/NY - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$61,120
+94.9%
1,6510.0%0.00%
+200.0%
Q2 2022$31,352
-29.6%
1,6510.0%0.00%
-50.0%
Q1 2022$44,560
-57.6%
1,651
-64.6%
0.00%
+100.0%
Q4 2021$105,080
-14.0%
4,6640.0%0.00%
-50.0%
Q3 2021$122,243
-18.1%
4,6640.0%0.00%0.0%
Q2 2021$149,295
-9.1%
4,6640.0%0.00%0.0%
Q1 2021$164,219
+9.8%
4,6640.0%0.00%0.0%
Q4 2020$149,574
-14.8%
4,6640.0%0.00%
-33.3%
Q3 2020$175,460
-15.9%
4,6640.0%0.00%
-25.0%
Q2 2020$208,7144,6640.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 111,550$274,4130.39%
Deep Track Capital, LP 2,837,818$6,981,0320.32%
apricus wealth, LLC 77,329$219,6140.19%
PARSONS CAPITAL MANAGEMENT INC/RI 873,312$2,148,3480.16%
Palo Alto Investors LP 732,400$1,801,7040.15%
RTW INVESTMENTS, LP 2,131,835$5,244,3140.10%
AdvisorShares Investments LLC 112,898$277,7290.08%
GSA CAPITAL PARTNERS LLP 271,524$6680.07%
Spotlight Asset Group, Inc. 20,000$49,2000.04%
Savior LLC 3,500$8,6100.04%
View complete list of RELMADA THERAPEUTICS INC shareholders